| 0 (0%) | 09-27 12:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 17.56 | 1-year : | 19.01 |
| Resists | First : | 15.03 | Second : | 16.28 |
| Pivot price | 14.66  |
|||
| Supports | First : | 13.02 | Second : | 10.84 |
| MAs | MA(5) : | 13.73 |
MA(20) : | 14.84 |
| MA(100) : | 13.32 |
MA(250) : | 18.37 |
|
| MACD | MACD : | -0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 5.2 |
D(3) : | 7.7 |
| RSI | RSI(14): 37.1  |
|||
| 52-week | High : | 27.12 | Low : | 11.06 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IART ] has closed above bottom band by 3.9%. Bollinger Bands are 11.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.59 - 13.67 | 13.67 - 13.75 |
| Low: | 12.84 - 12.93 | 12.93 - 13.03 |
| Close: | 13.05 - 13.19 | 13.19 - 13.33 |
Sat, 27 Sep 2025
What drives IART stock price - Portfolio Diversification Tips & Free ETF and Mutual Fund Comparisons - Early Times
Thu, 25 Sep 2025
Integra LifeSciences and LeMaitre Shares Are Falling, What You Need To Know - FinancialContent
Wed, 24 Sep 2025
Counterpoint Mutual Funds LLC Takes Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Tue, 23 Sep 2025
Integra LifeSciences (IART): Exploring Valuation Following Leadership Change in Medical Affairs - simplywall.st
Tue, 23 Sep 2025
Strs Ohio Takes Position in Integra LifeSciences Holdings Corporation $IART - MarketBeat
Mon, 22 Sep 2025
Integra LifeSciences Appoints Dr. Raymond Turner as New Chief Medical Officer - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 78 (M) |
| Shares Float | 59 (M) |
| Held by Insiders | 13.9 (%) |
| Held by Institutions | 95.3 (%) |
| Shares Short | 7,190 (K) |
| Shares Short P.Month | 6,840 (K) |
| EPS | -6.54 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.32 |
| Profit Margin | -30.9 % |
| Operating Margin | 7.8 % |
| Return on Assets (ttm) | 2.4 % |
| Return on Equity (ttm) | -39 % |
| Qtrly Rev. Growth | -0.7 % |
| Gross Profit (p.s.) | 11.97 |
| Sales Per Share | 20.79 |
| EBITDA (p.s.) | 3.92 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 71 (M) |
| Levered Free Cash Flow | 45 (M) |
| PE Ratio | -2.02 |
| PEG Ratio | 0 |
| Price to Book value | 0.99 |
| Price to Sales | 0.63 |
| Price to Cash Flow | 14.5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|